| Characteristic |
| Anxiety | Total | χ2 | Df | p | ||||
| Yes | No | |||||||||
| n | % | n | % | n | % | |||||
| Age in years | <50 | 7 | 10.3 | 61 | 89.7 | 68 | 100 | |||
| 51 - 60 | 3 | 5 | 57 | 95 | 60 | 100 |
|
|
| |
| >60 | 5 | 6.3 | 75 | 93.8 | 80 | 100 | 1.515 | 2 | 0.469 | |
| Gender | Male | 3 | 3.9 | 73 | 96.1 | 76 | 100 |
|
|
|
| Female | 12 | 9.1 | 120 | 90.9 | 132 | 100 | 1.907 | 1 | 0.167 | |
| Economic status | APL | 2 | 3.4 | 56 | 96.6 | 58 | 100 |
|
|
|
| BPL | 13 | 8.7 | 137 | 91.3 | 150 | 100 | 1.702 | 1 | 0.192 | |
| Site | Breast | 8 | 8.8 | 83 | 91.2 | 91 | 100 |
|
|
|
| Lung | 3 | 13 | 20 | 87 | 23 | 100 |
|
|
| |
| Esophagus | 0 | 0 | 1 | 100 | 1 | 100 |
|
|
| |
| Gastric | 0 | 0 | 8 | 100 | 8 | 100 |
|
|
| |
| Colo-rectum | 0 | 0 | 20 | 100 | 20 | 100 |
|
|
| |
| Head & Neck | 1 | 5.6 | 17 | 94.4 | 18 | 100 |
|
|
| |
| Pancreas | 0 | 0 | 3 | 100 | 3 | 100 |
|
|
| |
| Hepato-biliary | 1 | 14.3 | 6 | 85.7 | 7 | 100 |
|
|
| |
| Gynec | 2 | 28.6 | 5 | 71.4 | 7 | 100 |
|
|
| |
| Prostate | 0 | 0 | 3 | 100 | 3 | 100 |
|
|
| |
| Urology | 0 | 0 | 4 | 100 | 4 | 100 |
|
|
| |
| Hematological | 0 | 0 | 10 | 100 | 10 | 100 |
|
|
| |
| Sarcoma | 0 | 0 | 1 | 100 | 1 | 100 |
|
|
| |
| Myeloma | 0 | 0 | 10 | 100 | 10 | 100 |
|
|
| |
| Testis | 0 | 0 | 1 | 100 | 1 | 100 |
|
|
| |
| Others | 0 | 0 | 1 | 100 | 1 | 100 | 11.697 | 15 | 0.702 | |
| Stage | Stage I | 2 | 14.3 | 12 | 85.7 | 14 | 100 |
|
|
|
| Stage II | 3 | 5.6 | 51 | 94.4 | 54 | 100 |
|
|
| |
| Stage III | 4 | 6.1 | 62 | 93.9 | 66 | 100 |
|
|
| |
| Stage IV | 6 | 10.2 | 53 | 89.8 | 59 | 100 |
|
|
| |
| NA | 0 | 0 | 15 | 100 | 15 | 100 | 3.336 | 4 | 0.503 | |
| HPR | Squamous | 1 | 4.2 | 23 | 95.8 | 24 | 100 |
|
|
|
| Adeno/breast | 14 | 9.3 | 136 | 90.7 | 150 | 100 |
|
|
| |
| Others | 0 | 0 | 34 | 100 | 34 | 100 | 3.984 | 2 | 0.136 | |
| Reason for worry | Cancer | 15 | 7.9 | 174 | 92.1 | 189 | 100 |
|
|
|
| COVID | 0 | 0 | 2 | 100 | 2 | 100 |
|
|
| |
| Both | 0 | 0 | 17 | 100 | 17 | 100 | 1.625 | 2 | 0.444 | |
| Default of treatment | Yes | 2 | 4.3 | 44 | 95.7 | 46 | 100 |
|
|
|
| No | 13 | 8 | 149 | 92 | 162 | 100 | 0.724 | 1 | 0.395 | |